Sciatica Pro journal
The Name on the Bottle, and the Regulation Beside It
A regulation, a definition, a list item and a name. This post sets them beside each other, says what the bottle does carefully, and then stops.
101.93 the section, quoted rather than characterised
What 21 CFR 101.93 says, and the list item in it
A definition that is a functional test, and a list whose first item is a name.
This is the shortest finding on this site and the hardest one to write, because the discipline it needs is to state two facts and then stop.
21 CFR 101.93 is the section of the federal food regulations governing certain types of statements on dietary supplements: the structure/function claims a label may make, and the disclaimer that has to accompany them. It is why the back of almost every supplement bottle in the country carries the same paragraph in the same words.
Within that section there is a definition. A disease, for the purposes of the regulation, is: “damage to an organ, part, structure, or system of the body such that it does not function properly.”
Read it slowly. It is not a list of named illnesses. It is a functional test.
The same section then sets out the ways a claim about a disease may be made, because a regulation has to describe the thing it governs. The list is at (g)(2)(iv), and the first item on it, at (g)(2)(iv)(A), reads in full: “The name of the product;”
Six words and a semicolon. The regulation contemplates that a product name can itself be one of the ways a claim about a disease is made, which is why the list item exists. It is quoted rather than summarised on purpose: the value of this page depends on a reader checking that the words are the regulation’s and not this desk’s. The section is linked below.
2 federal pages on one condition
What MedlinePlus says sciatica is
Now the condition, from a federal consumer page rather than from this desk.
MedlinePlus Medical Encyclopedia, on sciatica: “Sciatica occurs when there is pressure on or damage to the sciatic nerve.”
And MedlinePlus, on what it is: “Sciatica is a symptom of a problem with the sciatic nerve, the largest nerve in the body.” With the symptoms: “When you have sciatica, you have pain, weakness, numbness, or tingling.”
The causes MedlinePlus names are mechanical in every case — “A ruptured intervertebral disk”, “Narrowing of the spinal canal that puts pressure on the nerve, called spinal stenosis” and “An injury such as a pelvic fracture.” — and on how often any of them can be identified at all, the page is blunt: “In many cases no cause can be found.”
So a reader now has a regulation defining a disease as damage to a part of the body such that it does not function properly, and a federal page describing sciatica as pressure on or damage to a nerve. Both pages are quoted at length on the sciatica page.
1 line, and it is the finding
The name on the bottle
The name of the product is the name of the condition.
And the second fact, which takes one line.
The product is called Sciatica Pro. The bottle prints it as Sciatica PRO +, with a plus. Either way, the name of the product is the name of the condition.
That is the whole of it: a regulation, a definition, a list item, a federal description of the condition, and a name. Five things, all printed somewhere a reader can go and look, and none of them supplied by this desk.
0 findings asserted about this product
And this is where this desk stops
State the regulation. State the name. Leave the conclusion with the reader.
And this is where this desk stops. It is worth being explicit about what that means, because the temptation to go one sentence further is the reason this section exists.
This site does not write that the product is illegal. It does not write that it is mislabelled, misbranded, non-compliant or in violation of anything. FDA has made no finding about this product, and neither has this desk. No warning letter, enforcement action, determination or complaint was supplied to this desk, none has been sought, and nothing here predicts that any will exist. A reader who finishes this post believing a regulator has acted has been misinformed, and not by anything written here.
There are good reasons for that beyond caution. Whether a particular name on a particular product crosses a line in a particular regulation is a judgement belonging to the agency that wrote the regulation, after a process with evidence and a right of reply in it. This desk has a photograph of a bottle and a marketing pack: enough to state the regulation and the name, nowhere near enough to reach a verdict, and a verdict reached on this much evidence would be worth nothing even if it happened to be right.
So the conclusion is left where it belongs, with a reader now holding exactly the information this desk is holding. A site that manufactured the missing verdict would be asking to be trusted about everything else on it, which is precisely the thing a reader cannot check.
2 claims on the front, both daggered
What the front of the bottle does carefully
Now the half of this that almost never gets written, and it belongs in the same post: the front of this bottle is built carefully.
It carries exactly two claims and no more: “Clinically Studied Ingredients†” and “Supports Nerve Health†” Both are followed by a dagger, and the dagger resolves on the back to the disclaimer in full: “THESE STATEMENTS HAVE NOT BEEN EVALUATED BY THE FOOD & DRUG ADMINISTRATION. THIS PRODUCT IS NOT INTENDED TO DIAGNOSE, TREAT, CURE OR PREVENT ANY DISEASE.”
Both are structure/function claims rather than disease claims. Neither says the product treats sciatica. Neither says it relieves, eases or cures anything. The front panel says it supports nerve health, and it marks the sentence so a reader can find the disclaimer. Plenty of labels in this category are not that careful.
The required wording, at 21 CFR 101.93(c)(1), is “This statement has not been evaluated by the Food and Drug Administration.” and “This product is not intended to diagnose, treat, cure, or prevent any disease.” Note what the first sentence concedes: FDA does not review a structure/function claim before it is used. So the one front-of-bottle claim a reader can actually audit is the other one, and this site audits it in the post on the trials.
The accurate description of this bottle holds two things at once. The claims on the front are constructed correctly, with the correct disclaimer. The name on the same bottle is the name of a condition. Both are true, and this page prints both.
2 spellings, one product
The other disagreement about the name
One smaller thing about the name, because it is the kind of detail that costs a buyer an afternoon. The bottle and the pack spell the product differently. The label prints Sciatica PRO +; the supplied pack prints Sciatica Pro, with no plus. This site reports both rather than choosing one, in line with the rule it applies everywhere: where the bottle and the pack disagree, both are printed and neither is resolved quietly.
It is cosmetic rather than a safety matter, and it has one practical consequence: if you are searching for the bottle in your hand, you may be searching for the wrong string. It is also not the only disagreement of its kind here — the two surfaces name two different companies, which is the subject of the next post.
3 things, none of them a verdict
What a reader can actually do with this
So what is a reader supposed to do with a page that deliberately declines to reach a conclusion? Three things, and none of them requires taking anybody’s word for anything.
Read the two documents yourself. Both are free, both are federal and both are linked in the sources below: the section of the regulation, and the MedlinePlus page on the condition. Ten minutes, and you are holding the same two facts this post is holding, from the sources rather than from a summary.
Ask the seller the question this desk cannot answer. Write to the order desk and ask what the product is intended for and what the company’s position is on the name. The order desk is +1 (302) 200-3480 and [email protected], and an answer in writing carries a date.
And know where a report goes, if you ever decide one is warranted. A problem with the product — a reaction, a bottle that does not match its label, a supplement sold to you as a treatment for a disease — goes to FDA, through MedWatch or the consumer complaint system. A problem with the selling goes to the Federal Trade Commission at reportfraud.ftc.gov. Both are free, both work better with the order ID and a screenshot in front of you, and both are linked below.
References
Sources
- Electronic Code of Federal Regulations. 21 CFR 101.93 — Certain types of statements for dietary supplements. www.ecfr.gov. Accessed October 11, 2026.
- U.S. Food and Drug Administration. Structure/Function Claims. www.fda.gov. Accessed October 11, 2026.
- MedlinePlus Medical Encyclopedia, U.S. National Library of Medicine. Sciatica (Medical Encyclopedia). medlineplus.gov. Accessed October 11, 2026.
- MedlinePlus, U.S. National Library of Medicine. Sciatica. medlineplus.gov. Accessed October 11, 2026.
- U.S. Food and Drug Administration. FDA 101: How to Use the Consumer Complaint System and MedWatch. www.fda.gov. Accessed October 11, 2026.
- Federal Trade Commission. Report Fraud to the FTC. reportfraud.ftc.gov. Accessed October 11, 2026.
Order Sciatica Pro from the official page
60 capsules a bottle, two capsules a day, thirty days a bottle. Ten ingredients and ten printed amounts, with no proprietary blend and about 677 mg of declared actives a serving. Price and guarantee are printed on the live checkout, so read them there before you pay. Order support +1 (302) 200-3480.
Price and guarantee are read on the checkout page — screenshot it with the date before you pay · ships from inside the US · order support +1 (302) 200-3480
Next
Keep reading
Sciatica, in the federal pages
The condition quoted from MedlinePlus and NINDS, and the regulation beside the name.
Read itWhat is claimed, and what is evidenced
The two front-of-bottle claims, and what each one can and cannot cover.
Read itTwo companies, one bottle
The other thing on this label that nothing supplied explains.
Read it